A study on MOTS-c for improving insulin sensitivity
Part of Hormones & metabolism clinical trials.
This trial tests an investigational peptide (MOTS-c) to see if it can improve how your body uses insulin. It's for adults with prediabetes and excess weight who are not yet on diabetes medications and can maintain a stable diet and activity level for 12 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your body mass index (BMI) is between 27 and 40.
- You have prediabetes, confirmed by a blood test at screening.
- Your weight has been stable (less than 5% change) for the past 3 months.
- You are willing to keep the same diet and activity level for 12 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how blood sugar levels change in people with prediabetes (higher-than-normal blood sugar but not yet diabetes). Researchers will use a small sensor to monitor your blood sugar and help understand what affects it, which could help prevent or delay type 2 diabetes.
This trial looks at how exercise training affects tiny particles released by muscles and fat cells that help the body communicate. You would do resistance exercise, and researchers will study these particles to see how they might improve metabolism and reduce diabetes risk.
This trial tests whether following a Mediterranean diet and doing cycling and rowing exercise can help lower blood sugar in women with prediabetes. It may help you find a safe way to prevent or delay diabetes.
This trial tests if empagliflozin, a medication typically used for diabetes, can help people with metabolic syndrome (a cluster of conditions like large waist size, high blood sugar, and high blood pressure). It may improve health and reduce the risk of heart disease.
This trial tests a drug that may help your body use insulin better and improve how your cells produce energy. It might lead to better blood sugar control and less insulin needed.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
Hear when a new Prediabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.